AAV

The Cell and Gene Therapy Catapult (CGT Catapult) has partnered with the UK Dementia Research Institute (UK DRI) to help advance the development of adeno-associated virus (AAV) based gene therapies for dementia.  Through the collaboration, the CGT Catapult will work with UK academic centres and the UK DRI to identify new AAV-based gene therapies that […]

 Mirus Bio outlines when to use transfection reagents, viral transduction or electroporation   No single delivery method is ideal for all situations, but researchers may routinely employ a suboptimal approach for the sake of familiarity or to avoid any start-up costs associated with new methods.   The uses of nucleic acid delivery have expanded from recombinant […]